Now that I read it, (thanks to D. Turtle) I can comment on the article from natural news snigger.
Isn't it funny how a comment on "how science can do better research" is interpreted by critics as "science is fraudulent and SUXS"
(NaturalNews) The vast majority of so-called scientific studies focused on cancer research are inaccurate and potentially fraudulent, suggests a new review published in the journal Nature.
1. Its a comment not a review article, which means Nature news doesn't know what the difference is. How do I know its a comment and not a review article. Why its listed under the heading Comment.
2. It does not suggest potentially fraudulent in the comment. Science which looks good in the lab but doesn't work in clinical trials is not fraudulent. But hey, lets use emotive language.
In fact lets quote the author Begley himself on this issue.
Begley wrote:
These investigators were all competent, well-meaning scientists who truly wanted to make advances in cancer research.
Yep, sounds like he is accusing them of fraud here.
A shocking 88 percent of 53 "landmark" studies on cancer that have been published in reputable journals over the years cannot be reproduced, according to the review, which means that their conclusions are patently false.
Long story short, the article is talking about what looks good in the lab, does not necessarily translate well in clinical trials. This is a given to anyone with half a brain. Thats why we have to have clinical trials in the first place.
What they are concerned about is that unlike other avenues of medical research, promising results in pre clinical work for cancer have a low success rate in clinical trials. They give some reasons for this, eg failure to use more than one cell line (not all cancers of the same type have the same cell line) etc.
C. Glenn Begley, a former head of global cancer research at drug giant Amgen and author of the review, was unable to replicate the findings of 47 of the 53 studies he examined. It appears as though researchers are simply fabricating findings that will garner attention and headlines rather than publishing what they actually discover, which helps them to maintain a steady stream of grant funding but deceives the public
Too bad Begley himself does not accuse the researchers of fabricating findings, and states the reasons why some lab work doesn't translate to clinical success.
"These are the studies the pharmaceutical industry relies on to identify new targets for drug development," said Begley about the false studies. "But if you're going to place a $1 million or $2 million or $5 million bet on an observation, you need to be sure it's true. As we tried to reproduce these papers we became convinced you can't take anything at face value."
If Begley said it, he certainly didn't say that in his comment. Just use Adobe and search for that passage in the PDF file, and its not there. Certainly the last line "As we tried to reproduce these papers we became convinced you can't take anything at face value" is a totally different tone to the one Begley uses in this comment about limitations of cancer research in the pre clinical phase. Especially when the article said this
Begley wrote:These results, although disturbing, do not mean that the entire system is flawed. There are many examples of outstanding research that has been rapidly and reliably translated into clinical benefit. In 2011, several new cancer drugs were approved, built on robust preclinical data.
The people accusing others of lying themselves resort to lying. Say it ain't so brother.
Begley says he cannot publish the names of the studies whose findings are false. But since it is now apparent that the vast majority of them are invalid, it only follows that the vast majority of modern approaches to cancer treatment are also invalid.
No, it implies that the majority of
cancer research in the pre clinical trial phase needs to be improved. Cancer
treatment is in the post clinic trial phase. Remember, even if it looks good in a lab, it needs to be tested in the real world before we can market it. The article is commenting on why good results in pre clinical lab work doesn't translate into good results in clinical trials. The fact Natural news doesn't know the difference tells me quite a lot about them. But it gets better. Remember this comment from your precious author.
Begley wrote:These results, although disturbing, do not mean that the entire system is flawed. There are many examples of outstanding research that has been rapidly and reliably translated into clinical benefit. In 2011, several new cancer drugs were approved, built on robust preclinical data.
Naturally Natural News (Nice alliteration) doesn't quote this comment. It wouldn't fit with the organisation's avowed
goal to "empower individuals to make positive changes in their health." And that quote in "" is actually what they said.
Back in 2009, researchers from the University of Michigan's Comprehensive Cancer Center also published an analysis that revealed many popular cancer studies to be false. As can be expected, one of the primary causes of false results was determined to be conflicts of interest that tended to favor "findings" that worked out best for drug companies rather than for the people
This is separate from the article, so its harder for me to comment. However its hard to spin a conflict of interest (hint the word conflict doesn't even appear in the article) from Begley's comment when its actually in Big Pharma's interest to improve the pre clinical lab work. Why is it in their interest? So they don't waste money on a clinical trial which doesn't work.
God these guys are fucking retards.
Does anyone know if it violates copyright to post in on a scrib account? I am tempted to do that and then post this rebuttal on the other message board.
Once again thanks to D. Turtle.
Never apologise for being a geek, because they won't apologise to you for being an arsehole. John Barrowman - 22 June 2014 Perth Supernova.
Countries I have been to - 14.
Australia, Canada, China, Colombia, Denmark, Ecuador, Finland, Germany, Malaysia, Netherlands, Norway, Singapore, Sweden, USA.
Always on the lookout for more nice places to visit.